ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
3.640
+0.440 (13.75%)
Aug 14, 2025, 11:36 AM - Market open
ReShape Lifesciences Market Cap
ReShape Lifesciences has a market cap or net worth of $8.68 million as of August 14, 2025. Its market cap has increased by 42.57% in one year.
Market Cap
8.68M
Enterprise Value
5.25M
1-Year Change
42.57%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since January 25, 2019, ReShape Lifesciences's market cap has increased from $2.57M to $8.68M, an increase of 238.27%. That is a compound annual growth rate of 20.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 568.70B |
| Johnson & Johnson | 418.64B |
| AbbVie | 350.91B |
| UnitedHealth Group | 232.90B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 227.93B |
| Novo Nordisk | 222.88B |